![Ross Barrow](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Ross Barrow served as the Chief Executive Officer & Director at Paranta Biosciences Ltd. and as a Non-Executive Director at Acrux Ltd.
Former positions of Ross Barrow
| Companies | Position | End |
|---|---|---|
| ACRUX LIMITED | Director/Board Member | 27/02/2015 |
Paranta Biosciences Ltd.
 Paranta Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Develops PB01 (recombinant human follistatin-288) for the treatment of fibrotic and inflammatory diseases | Chief Executive Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
11
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Acrux Ltd.
 Acrux Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Paranta Biosciences Ltd.
Paranta Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Develops PB01 (recombinant human follistatin-288) for the treatment of fibrotic and inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- Ross Barrow
